Ignite Creation Date:
2024-05-06 @ 6:02 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05528952
Status:
RECRUITING
Last Update Posted:
2023-11-13
First Post:
2022-09-01
Brief Title:
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Sponsor:
Organization:
Centre Hospitalier Universitaire de Besancon